Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma

Journal of Pathology

Volumn 225, Issue 3, 2011, Pages 353-363

  Bennani Baiti, Idriss M ^a   Aryee, Dave Nt ^a   Ban, Jozef ^a   MacHado, Isidro ^b   Kauer, Maximilian ^a   Mühlbacher, Karin ^a   Amann, Gabriele ^c   Llombart Bosch, Antonio ^b   Kovar, Heinrich ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

bHLH transcription factors; covariance meta analysis; Ewing tumours; EWS ETS; fusion oncogenes; medulloblastoma; Notch; paediatric cancers; rhabdomyosarcoma; tumour suppressors

Indexed keywords

JAGGED1; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NUCLEIC ACID BINDING PROTEIN; PROTEIN HEY 1; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CLONOGENESIS; COLON ADENOCARCINOMA; EWING SARCOMA; EWING SARCOMA FAMILY OF TUMOR; GENE EXPRESSION PROFILING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PANCREAS CARCINOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE NEOPLASMS; CELL NUCLEUS; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; RECEPTORS, NOTCH; SARCOMA, EWING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 80054720133     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2966     Document Type: Article

References (57)

1. Artavanis-Tsakonas S, Rand MD, Lake RJ,. Notch signaling: cell fate control and signal integration in development. Science 1999; 284: 770-776. (Pubitemid 29291335)
2. Collier JR, Monk NA, Maini PK, et al., Pattern formation by lateral inhibition with feedback: a mathematical model of delta-notch intercellular signalling. J Theor Biol 1996; 183: 429-446. (Pubitemid 27033749)
3. Leong KG, Niessen K, Kulic I, et al., Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med 2007; 204: 2935-2948. (Pubitemid 350179562)
4. Wang Z, Li Y, Kong D, et al., The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr Drug Targets 2010; 11: 745-751.
5. Leong KG, Karsan A,. Recent insights into the role of Notch signaling in tumorigenesis. Blood 2006; 107: 2223-2233. (Pubitemid 43345539)
6. Thiery JP, Acloque H, Huang RY, et al., Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
7. Dotto GP,. Notch tumor suppressor function. Oncogene 2008; 27: 5115-5123.
8. Sjolund J, Manetopoulos C, Stockhausen MT, et al., The Notch pathway in cancer: differentiation gone awry. Eur J Cancer 2005; 41: 2620-2629. (Pubitemid 41607552)
9. Rizzo P, Osipo C, Foreman K, et al., Rational targeting of Notch signaling in cancer. Oncogene 2008; 27: 5124-5131.
10. Purow B,. Notch inhibitors as a new tool in the war on cancer: a pathway to watch. Curr Pharm Biotechnol 2009; 10: 154-160.
11. Miyagawa Y, Okita H, Nakaijima H, et al., Inducible expression of chimeric EWS/ETS proteins confers Ewing's family tumor-like phenotypes to human mesenchymal progenitor cells. Mol Cell Biol 2008; 28: 2125-2137. (Pubitemid 351429961)
12. Janknecht R,. EWS-ETS oncoproteins: the linchpins of Ewing tumors. Gene 2005; 363: 1-14. (Pubitemid 41691887)
13. Ban J, Bennani-Baiti IM, Kauer M, et al., EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma. Cancer Res 2008; 68: 7100-7109.
14. Baliko F, Bright T, Poon R, et al., Inhibition of notch signaling induces neural differentiation in Ewing sarcoma. Am J Pathol 2007; 170: 1686-1694. (Pubitemid 47339313)
15. Real PJ, Tosello V, Palomero T, et al., Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nature Med 2009; 15: 50-58.
16. Jaleco AC, Neves H, Hooijberg E, et al., Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J Exp Med 2001; 194: 991-1002.
17. Stylianou S, Clarke RB, Brennan K,. Aberrant activation of notch signaling in human breast cancer. Cancer Res 2006; 66: 1517-1525. (Pubitemid 43259933)
18. Fan X, Matsui W, Khaki L, et al., Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 2006; 66: 7445-7452. (Pubitemid 44289197)
19. Sansone P, Storci G, Tavolari S, et al., IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 2007; 117: 3988-4002. (Pubitemid 350224108)
20. Zeuner A, Francescangeli F, Signore M, et al., The Notch2-Jagged1 interaction mediates stem cell factor signaling in erythropoiesis. Cell Death Differ 2011; 18: 371-380.
21. Bennani-Baiti IM, Cooper A, Lawlor ER, et al., Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma. Clin Cancer Res 2010; 16: 3769-3778.
22. Henderson SR, Guiliano D, Presneau N, et al., A molecular map of mesenchymal tumors. Genome Biol 2005; 6: R76.
23. Wachtel M, Dettling M, Koscielniak E, et al., Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1. Cancer Res 2004; 64: 5539-5545. (Pubitemid 39095545)
24. Su AI, Cooke MP, Ching KA, et al., Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A 2002; 99: 4465-4470. (Pubitemid 34286008)
25. Gayen AK,. The frequency distribution of the product-moment correlation coefficient in random samples of any size drawn from non-normal universes. Biometrika 1951; 38: 219-247.
26. Gao J, Song Z, Chen Y, et al., Deregulated expression of Notch receptors in human hepatocellular carcinoma. Dig Liver Dis 2008; 40: 114-121.
27. Rodilla V, Villanueva A, Obrador-Hevia A, et al., Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer. Proc Natl Acad Sci U S A 2009; 106: 6315-6320.
28. Doucas H, Mann CD, Sutton CD, et al., Expression of nuclear Notch3 in pancreatic adenocarcinomas is associated with adverse clinical features, and correlates with the expression of STAT3 and phosphorylated Akt. J Surg Oncol 2008; 97: 63-68.
29. McGill MA, McGlade CJ,. Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J Biol Chem 2003; 278: 23196-23203. (Pubitemid 36830386)
30. Borggrefe T, Oswald F,. The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell Mol Life Sci 2009; 66: 1631-1646.
31. Noseda M, Fu Y, Niessen K, et al., Smooth muscle alpha-actin is a direct target of Notch/CSL. Circ Res 2006; 98: 1468-1470. (Pubitemid 44297068)
32. Ota MS, Kaneko Y, Kondo K, et al., Combined in silico and in vivo analyses reveal role of Hes1 in taste cell differentiation. PLoS Genet 2009; 5: e1000443.
33. Nguyen BC, Lefort K, Mandinova A, et al., Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev 2006; 20: 1028-1042.
34. Palomero T, Lim WK, Odom DT, et al., NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A 2006; 103: 18261-18266. (Pubitemid 44871646)
35. Carlson ME, Silva HS, Conboy IM,. Aging of signal transduction pathways, and pathology. Exp Cell Res 2008; 314: 1951-1961. (Pubitemid 351649367)
36. Sang L, Coller HA, Roberts JM,. Control of the reversibility of cellular quiescence by the transcriptional repressor HES1. Science 2008; 321: 1095-1100.
37. Ramalho-Santos M, Yoon S, Matsuzaki Y, et al., 'Stemness': transcriptional profiling of embryonic and adult stem cells. Science 2002; 298: 597-600. (Pubitemid 35215313)
38. Murata K, Hattori M, Hirai N, et al., Hes1 directly controls cell proliferation through the transcriptional repression of p27Kip1. Mol Cell Biol 2005; 25: 4262-4271. (Pubitemid 40617671)
39. Kovar H, Aryee DN, Jug G, et al., EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro. Cell Growth Differ 1996; 7: 429-437. (Pubitemid 26362087)
40. Lambert G, Bertrand JR, Fattal E, et al., EWS fli-1 antisense nanocapsules inhibits Ewing sarcoma-related tumor in mice. Biochem Biophys Res Commun 2000; 279: 401-406. (Pubitemid 32016729)
41. Ouchida M, Ohno T, Fujimura Y, et al., Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts. Oncogene 1995; 11: 1049-1054.
42. Thompson AD, Teitell MA, Arvand A, et al., Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells. Oncogene 1999; 18: 5506-5513. (Pubitemid 29481497)
43. Guentchev M, McKay RD,. Notch controls proliferation and differentiation of stem cells in a dose-dependent manner. Eur J Neurosci 2006; 23: 2289-2296. (Pubitemid 43742861)
44. Mazzone M, Selfors LM, Albeck J, et al., Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells. Proc Natl Acad Sci U S A 2010; 107: 5012-5017.
45. Grabher C, von Boehmer H, Look AT,. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nature Rev Cancer 2006; 6: 347-359.
46. Radtke F, Raj K,. The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nature Rev Cancer 2003; 3: 756-767. (Pubitemid 37328814)
47. Zweidler-McKay PA,. Notch signaling in pediatric malignancies. Curr Oncol Rep 2008; 10: 459-468.
48. Stockhausen MT, Sjolund J, Axelson H,. Regulation of the Notch target gene Hes-1 by TGFalpha induced Ras/MAPK signaling in human neuroblastoma cells. Exp Cell Res 2005; 310: 218-228. (Pubitemid 41398083)
49. Ingram WJ, McCue KI, Tran TH, et al., Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signalling. Oncogene 2008; 27: 1489-1500. (Pubitemid 351317457)
50. Wall DS, Mears AJ, McNeill B, et al., Progenitor cell proliferation in the retina is dependent on Notch-independent Sonic hedgehog/Hes1 activity. J Cell Biol 2009; 184: 101-112.
51. Curry CL, Reed LL, Nickoloff BJ, et al., Notch-independent regulation of Hes-1 expression by c-Jun N-terminal kinase signaling in human endothelial cells. Lab Invest 2006; 86: 842-852. (Pubitemid 44100482)
52. Jarriault S, Brou C, Logeat F, et al., Signalling downstream of activated mammalian Notch. Nature 1995; 377: 355-358.
53. Maier MM, Gessler M,. Comparative analysis of the human and mouse Hey1 promoter: Hey genes are new Notch target genes. Biochem Biophys Res Commun 2000; 275: 652-660.
54. Smith CL, Hager GL,. Transcriptional regulation of mammalian genes in vivo. A tale of two templates. J Biol Chem 1997; 272: 27493-27496. (Pubitemid 27473531)
55. Sang L, Roberts JM, Coller HA,. Hijacking HES1: how tumors co-opt the anti-differentiation strategies of quiescent cells. Trends Mol Med 2010; 16: 17-26.
56. Fischer A, Gessler M,. Delta-Notch-and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors. Nucleic Acids Res 2007; 35: 4583-4596. (Pubitemid 47250333)
57. Arai MA, Masada A, Ohtsuka T, et al., The first Hes1 dimer inhibitors from natural products. Bioorg Med Chem Lett 2009; 19: 5778-5781.